Trial Profile
Multicenter Randomized Phase 2 Trial of Gemcitabine - Platinum With or Without Trastuzumab in Advanced or Metastatic Urothelial Carcinoma With HER2 Overexpression
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Carboplatin; Cisplatin; Gemcitabine
- Indications Bladder cancer
- Focus Therapeutic Use
- 17 Apr 2013 New trial record